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Abstract
Background: The cholinergic and opioid systems play important roles in modulating inflammation. This study tests
whether auricular acupuncture (AA) produces anti-inflammatory effects via opioid and peripheral cholinergic
receptors in a rat model.
Methods: Rats were anesthetized with chloral hydrate and inflammation was induced by intraplantar injection of
carrageenan. Electroacupuncture was performed at auricular points bilaterally. The severity of inflammation was
assessed using changes in paw volume and thermal and mechanical pain thresholds of the rats during recovery
from anesthesia.
Results: Electroacupuncture at selected auricular acupoints significantly reduced paw edema and mechanical
hyperalgesia, with no significant effect on thermal hyperalgesia. The anti-edematous and analgesic effects of AA
were abolished by blockade of peripheral cholinergic muscarinic receptors with methyl atropine. Blockade of local
muscarinic receptors at the inflamed site with a small dose of atropine also antagonized the anti-edematous effect
of AA. By contrast, systemic opioid receptor blockade with naloxone did not antagonize the anti-inflammatory
effects of AA.
Conclusion: This study discovers a role of peripheral muscarinic receptors in mediating the anti-inflammatory
effects of AA. The cholinergic muscarinic mechanism appears to be more important than the opioid mechanism in
the anti-inflammatory action of AA.
Background
Auricular acupuncture (AA) has been used for a wide
varieties of pain conditions, such as cancer pain [1],
chronic spinal pain [2,3], phantom limb pain [4], post-
operative pain [5] and wound care in patients with
burns [6]. Unlike body acupuncture, which has been
widely studied for its analgesic mechanisms [7], the
mechanism of AA in pain relief remains largely uninves-
tigated. Since the auricle is innervated by a mix of V,
VII, IX and X cranial sensory nerves as well as cervical
spinal afferents [8-10] and has central connections dis-
tinct from those of body acupoints, the afferent signal-
ing (hence the physiological responses) produced by AA
may be substantially different from those produced by
body acupuncture.
The anti-inflammatory action of AA is of particular
interest as inflammation is a major cause of pain. A choli-
nergic anti-inflammatory pathway involving activation of
vagal efferent nerves was described [11]. Stimulation of
the vagus nerve inhibits the development of carrageenan
(CA)-induced paw edema and local production of cyto-
kines, and local administration of the vagus nerve neuro-
transmitter acetylcholine or cholinergic agonists reduces
acute inflammation [12]. Acupuncture may activate the
cholinergic anti-inflammatory pathway in treatment of
inflammatory diseases [11]. Stimulation of auricular affer-
ents excites vagal efferents [13] which may in turn modu-
late the cholinergic anti-inflammatory pathway. Moreover,
opioids were found to be related to the analgesic effects of
AA [14].
The present study tests whether auricular acupuncture
produces anti-inflammatory effects via opioid and per-
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Rationale
A CA-induced inflammation model responsive to activa-
tion of the cholinergic anti-inflammatory pathway [12]
was used as previously described [15]. The optimal loca-
tion for AA, the appropriate intensity of electroacupunc-
ture stimulation and the effects of AA given at different
time points were determined with three series of pilot
experiments. We then studied the analgesic and anti-
edematous effects of AA under the optimal stimulation
parameters and examined the antagonistic effects of
mascurinic and opioid receptor antagonists.
Animal treatments
A total of 238 adult male Sprague-Dawley rats weighting
200-260 g were purchased from the Laboratory Animal
Services Centre, The Chinese University of Hong Kong
and were acclimatized for three days or over with food
and water accessible ad libitum. The experimental proto-
cols were approved by the Committee on the Use of
Human & Animal Subjects in Teaching and Research of
the Hong Kong Baptist University. The experiments were
carried out in accordance with the Ethical Guidelines for
Investigations of Experimental Pain in Conscious Animals
published by the International Association for the Study of
Pain [16]. Anesthesia was induced with intraperitoneal
(i.p.) injection of 400 mg/kg choral hydrate (Fluka, USA),
which provided stable anesthesia for 60-80 minutes. In
some experiments, animals were kept fully anesthetized
with additional anesthetics (20 mg of choral hydrate)
when they showed blinking reflex or movements to hand-
ling [15]; and in other experiments, animals were allowed
to wake up for behavioral testing. The fully anesthetized
preparation was used for all the pilot experiments and for
Protocol 3 described in the subsection Experimental pro-
tocols. Under anesthesia, local inflammation was induced
by subcutaneous injection of 50 μlo f2 %C Al a m b d a
(Sigma-Aldrich, USA) in 0.9% saline at the center of the
left paw on the planter surface. At the end of the experi-
ments, animals were sacrificed with overdosed pentobarbi-
tal and cervical dislocation.
Measurements of pain and inflammation
Paw volume was measured at the level of the calcaneus
with a plethysmometer (Ugo Basile, Italy) as previously
described [15]. Nociception thresholds were evaluated
with measurement of thermal and pressure stimuli before
anesthesia and at least four hours after the initial anes-
thetic injection (when the rats had completely recovered
from anesthesia and displayed normal walking and
exploratory behaviors so that reliable algesic tests could
be carried out). Thermal and mechanical hyperalgesia
were assessed according to the methods described
previously [17,18]. Briefly, for measurement of the
latency of paw withdrawal upon thermal stimulation, the
animals were placed in a plexiglass enclosure on top of a
glass plate and habituated for at least 30 minutes. A ther-
mal stimulator (IITC, USA) was positioned under the
glass plate and the focus of the projection bulb was direc-
ted to the middle of the plantar surface of the animal
with the aid of a mirror attached to the stimulator. The
intensity of the light source was adjusted to the level that
caused the paw to withdraw at 10-12 seconds in normal
rats and a cut-off time of 20 seconds was set so as to pre-
vent tissue damage. The thermal pain threshold was
defined as the latency of reflex paw withdrawal. Change
in thermal pain threshold was expressed as percentage
change in paw withdrawal time from baseline. The paw
pressure test was performed with an electronic pressure-
meter [19] consisting of a polypropylene pipette tip (dia-
meter: 1 mm) adapted to a hand-held electronic force
transducer connected to a data acquisition system (AD
Instruments, Australia). Animals were stabilized in a cov-
ered acrylic cage with a wire grid floor and the polypro-
pylene tip was applied perpendicularly to each of the five
distal footpads with a gradual increase in pressure. The
pressure required to induce a flexor response was taken
as the pain threshold for each footpad and the mean
value of pain thresholds for the five footpads was used as
the pressure pain threshold for each animal. Change in
pressure pain threshold was expressed as percentage
change from the pre-inflammation baseline taken before
the induction of anesthesia and CA injection. The asses-
sor who took the above measurements was blinded to the
group status of the animal.
Localization of auricular acupoints
Auricular acupoints may typically correspond to regions
of low electrical impedance [20]. To identify low impe-
dance points, we carried out pilot experiments with six
rats according to a method described previously [21].
We divided the rat auricle into four areas based on sur-
face landmarks: anterio-medial (area A), posterio-medial
(area B), posterio-lateral (area C) and anterio-lateral
(area D) (Figure 1A) corresponding to the cymba con-
chae, cavita conchae, helix-scapha-antihelix and triangu-
lar fossa-crura anthelicis respectively in human. A total
of 19 points were identified anatomically according to
nearby landmarks and selected for measurements
(Figure 1B). A point with impedance lower than 100 kΩ
was regarded as a low impedance point [20]. Low impe-
dance points were mainly found in area A (Figure 1C)
corresponding to the cymba conchae in human.
To determine the relationship between acupoint loca-
tion and anti-inflammatory efficacy, we carried out pilot
experiments to compare the anti-edematous effects of
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mals. AA (0.7-1.0 mA) was applied at one of the five
auricular points for 60 minutes after CA injection. The
m a x i m a lp a wv o l u m e( m e a n±S D )r e a c h e da tf o u r
hours post-CA injection was 26.4 ± 13.6% for A2,
25.6 ± 6.6% for A4, 26.3 ± 8.2% for C5, 28.0 ± 17.7%
for D4 and 33.8 ± 13.3% for D2 (n =1 0p e rg r o u p ;
Figure 1B) with the volumes of A2, A4, C5 significantly
lower than that of the control (39.8 ± 14.7, P < 0.001).
Therefore, we selected A4, the point of least edema, for
later experiments.
AA using electrical stimulation
A pair of stainless steel needles (Carbo, China;
0.2 mm×13 mm) inserted 1 mm deep perpendicularly at
A4 bilaterally were connected to an electroacupuncture
Figure 1 Illustration of auricular acupoint identification. A: Photo of the rat right auricle, with lines indicating the anatomical landmarks.
B: Drawing of the rat right auricle showing the location of points where electrical impedance was measured. The paw volumes after CA
injection and electroacupuncture (0.7-1 mA, 4 Hz) at sites A2, A4, C5, D2 and D5 are shown in the respective boxes, and they are indicative of
the anti-inflammatory efficacy of the given site. C: Histograms showing the electrical impedance obtained from the auricle (mean ± SD, n = 6).
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tangular pulses (0.45 ms in duration) in alternating
polarity for 45 minutes of stimulation. Pilot experiments
were carried out to determine the optimal intensity of
stimulation in fully anesthetized animals with paw
edema as the outcome measure. Five groups of animals
(n = 10-12 per group) were given AA at the A4 site at
an intensity of either 0 mA (sham electroacupuncture),
0 . 5m A ,0 . 7m A ,1 . 0m Ao r1 . 5m Ao n eh o u ra f t e r
induction of inflammation. The 0.7 mA and 1.0 mA
groups had the strongest inhibitory effect on edema.
Therefore, for all later experiments, the stimulation
intensity was set to 0.7-1.0 mA.
AA at various time points
A separate series of pilot experiments was carried out to
determine if the timing of AA was also important in
producing anti-inflammatory effects. Thirty-two (32)
rats were randomly divided into four groups (n =8
each) which received either no AA treatment (control)
o rA Aa tt h r e et i m ep o i n t s .A Ag i v e ne i t h e ro n eh o u r
prior to CA injection, immediately after CA injection or
one hour after CA injection had similar anti-edematous
effects that were significantly different (P < 0.05) from
that of control. Therefore, in later experiments we
applied electroacupuncture either one hour prior to CA
injection or immediately after CA injection.
Receptor blockades
To determine the receptor systems involved in the
action of AA, we injected (ip), 10 minutes prior to AA,
opioid receptor antagonist naloxone hydrochloride (NX;
Sigma, USA; 5 mg/kg in 0.2 ml of saline), the peripheral
muscarinic receptor antagonist atropine methyl bromide
(AT, Sigma, USA; 2 mg/kg in 0.2 ml of saline) or 0.2 ml
of the injection vehicle, namely normal saline (NS).
A supplementary dose of NX (2.5 mg/kg in 0.1 ml NS)
was given again 30 minutes after the first NX injection
[15,22] and the same amount of NS was given to the
other groups as control.
In a separate series of experiments, immediately after
CA injection, a small dose of AT (12.5 μgi n5 0μlo f
saline) or vehicle was injected intraplantarly at either
the left or right paw (Protocol 3 below). All drugs were
freshly prepared by a technician unaware of the experi-
mental procedures and the drug identity of the animal
group status was revealed to the experimenter only after
completion of the testing.
Experimental protocols
Protocol 1
To determine the anti-inflammatory effects of AA, we
tested the animals for thermal and pressure pain thresh-
olds and measured paw volumes. They were then
anesthetized with choral hydrate and randomly divided
into two groups (n = 10 per group). One group received
AA treatment for 45 minutes while the other received
no treatment to serve as control. Then both groups
were given CA injection. The animals were fully con-
scious two hours after anesthesia (at about one hour
after CA injection) and thermal and pressure pain
thresholds as well as paw volumes were assessed again
three hours after CA injection (Figure 2).
Protocol 2
To determine the effects of peripheral muscarinic block-
ade and systemic opioid blockades, we used a 2×3 full
factorial design (n = 12 per group). On each experimen-
tal day six rats were first tested for thermal and pressure
pain thresholds and had paw volumes measured. They
were then anesthetized and allocated to one of the three
pairs that received either injection of naloxone (5 mg/kg
ip), methyl-atropine (AT, 2 mg/kg ip) or NS. One rat
in each pair was then given AA for 45 minutes 10 min-
utes after the injection. A second ip injection of NX
(2.5 mg/kg) or NS (for the non-NX groups) was given
with 30 minutes after the first injection during AA.
After AA, all animals were given intraplantar CA injec-
tion and thermal and pressure pain thresholds as well as
paw volumes were assessed again three hours after CA
injection (Figure 2).
Figure 2 Schematic drawings showing the time lines for each
experimental protocol. Please note that time indicators are not
drawn to scale. In Protocol 2, intraperitoneal injection of receptor
antagonists (NX, naloxone; AT, atropine) or the vehicle normal saline
(NS) was made 10 minutes before auricular acupuncture (AA) and
20 minutes after AA. In Protocol 3, intraplantar injection of AT/NS
was made following CA injection, just before AA.
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To assess the role of local muscarinic receptors, we used
paw volumes as the measure of inflammation in fully
anesthetized animals. After anesthesia, the paw volumes
were measured and CA was injected to induce inflam-
mation. Then animals were divided into three groups
(n = 8 per group) and received intraplantar injections
of (i) AT (12.5 μgi n5 0μl of vehicle) at the left (CA-
injected) paw with vehicle at the right paw or (ii) AT at
the right paw with vehicle at the left paw or (iii) vehicle at
both paws. Then AA was given for 45 minutes and the
paw volumes were measured at the fourth hour (Figure 2).
Statistical analysis
Statistical analysis was performed with SPSS (Version 11,
SPSS Inc., USA). Paw edema was calculated by the follow-
ing formula: V = (V1/V0-1) ×100%, where V is the change
in paw volume, V0 is the baseline paw volume and V1 is
the paw volume after induction of inflammation. Changes
in thermal and mechanical thresholds were expressed by
percentage of the baseline according to this formula: T =
T1/T0, where T is the change in threshold, T0 is the base-
line threshold reading and T1 is the threshold reading
after induction of inflammation. Data were expressed as
mean ± SD. One-way ANOVA followed by double-sided
Dunnett’sTpost-hoc comparison was performed to com-
pare the effects of several experimental groups with the
control. Two-way ANOVA followed by Tukey’sH S Dpost-
hoc comparison was performed to compare the combined
effects from AA and receptor antagonists on several indi-
cators of inflammation. Differences were considered statis-
tically significant when P < 0.05.
Results
Anti-inflammatory effects of AA
In conscious animals at the third hour post-CA injection
(n = 10), for the CA-injected paw, the paw volume (mean
± SD) was 47.6 ± 11.1% over the baseline; and the pressure
and thermal pain thresholds were significantly reduced to
41.7 ± 14.3% and 71.1 ± 35.5% of the baseline respectively.
In the CA-injected paw of animals with AA (n =1 0 ) ,t h e
edema was 26.8 ± 11.0%, significantly less than that of
control (P < 0.001); and the pressure pain threshold was
67.3 ± 24.3%, significantly higher than that of control (P =
0.012). However, there was no significant difference (P >
0.05) between control and treatment groups in thermal
pain threshold. For the non-injected paw, there was no
difference between the baseline and post-CA injection or
between the control and treatment groups (Figure 3).
Effects of peripheral muscarinic blockade or systemic
opioid blockade
A 2×3 full factorial design was used to test whether
opioid or peripheral muscarinic receptors were involved
in the action of AA (n =1 2p e rg r o u p ) .I nt h et h r e e
groups without AA, neither NX nor AT had any effect
on edema, thermal or pressure pain threshold in the
CA-induced inflammation model (Figure 4). In the AA
treatment groups, however, AT antagonized the effects
of AA on edema reduction (AA+NS: 33.8 ± 9.12% vs.
AA+AT: 49.4 ± 12.2%; P = 0.004) and on pressure pain
threshold elevation (AA+NS: 50.2 ± 14.9% vs. AA+AT:
35.7 ± 7.8%; P = 0.042). By contrast, NX had no effect
Figure 3 Histograms showing the effects of auricular
acupuncture (AA) on paw volume, thermal pain threshold and
pressure pain threshold in two groups of conscious animals
(No AA or AA) that had CA-induced inflammation. Baseline
values were obtained before the induction of brief anesthesia and
CA injection. Paw volume is expressed as percentage increase from
the baseline and thermal or pain threshold is shown as percentage
change from the baseline. *P < 0.05, comparison between AA and
No AA, n = 10 per group.
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actions of AA (both p > 0.05), but potentiated the
analgesic effect of AA on thermal pain threshold (AA+
NS: 52.1 ± 18.0% vs. AA+NX: 79.5 ± 24.0%; P = 0.018).
Effect of local muscarinic receptor blockade
To further examine the contribution of muscarinic
receptors at the site of inflammation, we investigated
the effect of local AT administration on the anti-edema-
tous effect of AA in fully anesthetized animals with paw
edema as the outcome measure. The group with AT
injection at the site of inflammation had significantly
higher edema values than the groups with vehicle con-
trol injection or contralateral AT injection (Ipsilateral
AT: 35.5 ± 4.8% vs. NS-NS: 23.5 ± 9.7% or Contralateral
AT: 25.2 ± 8.1%, n =8p e rg r o u p ;P = 0.03 between
Ipsilateral AT and NS-NS) (Figure 5), indicating that
blockade of muscarinic receptors at the site of inflam-
mation reduced the anti-edematous effect of AA.
Discussion
Using the CA-induced inflammation model, we demon-
strate in the present study that peripheral muscarinic
receptors, especially those at the site of inflammation,
are important in mediating the anti-inflammatory effects
of AA. This is in line with the findings that local mus-
carine application increases mechanical nociceptive
thresholds of the skin, which are mediated by M2 recep-
tors [23]. The activation of local M2 receptors leads to
nociceptor desensitization b yi n h i b i t i n gt h er e l e a s eo f
calcitonin-gene related peptide (CGRP), a pro-inflamma-
tory neuropeptide in nerve endings [24]. In the formalin
model of orofacial nociception in rats, administration of
the M2 agonist arecaidine dose-dependently inhibits
nocifensive behavior [25]. These findings indicate an
important role for muscarinic receptors, especially M2
receptor, in the cholinergic modulation of neurogenic
Figure 4 Histograms showing the effects of methyl atropine
(2 mg/kg, ip) and naloxone (5 mg/kg followed by 2.5 mg/kg, ip)
on the effects of auricular acupuncture (AA) in conscious
animals with CA-induced inflammation. Baseline values were
obtained before the induction of brief anesthesia and CA injection.
Paw volume is expressed as percentage increase from the baseline
and thermal or pain threshold is shown as percentage change from
the baseline. *P < 0.05, comparison between AA and No AA with the
same ip injection (vehicle, naloxone or atropine), n = 12 per group.
Figure 5 Histograms showing the effects of local muscarinic
receptor blockade on the anti-edematous effect of auricular
acupuncture (AA). All three groups of animals (n = 8 per group)
were continuously anesthetized, and received CA-induced
inflammation and AA treatment. The first group received
intraplantar injections of normal saline (vehicle control) at both
paws; the second group was given intraplantar injection of methyl
atropine (12.5 μg) ipsilateral to the inflamed side and vehicle
injection on the contralateral side; and the third group received the
same injection of methyl atropine at the contralateral side, to
control for the possible systemic effect of atropine. * P < 0.05, n =
8 per group.
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cessing. The present study shows that muscarinic recep-
tors were involved in mediating the anti-edematous and
analgesic effects of AA in CA-induced inflammation
consisting of both neurogenic and non-neurogenic com-
ponents [26,27]. It is to be determined, however, which
subtypes of muscarinic receptor are involved in mediat-
ing effects of AA.
Results of our pilot study (Figure 1) indicated that the
anti-inflammatory effect of AA was best evoked from
the concha region. This region has preferential innerva-
tion from vagal sensory afferents [8,9]. Stimulation of
the concha region consistently causes vagal efferent acti-
vation, resulting in stomach contraction and bradycardia
reversible by atropine [13]. It is assumed that AA also
activates vagal efferent nerves in current experiments.
However, while evidence suggests that the hindpaw and
dorsal root ganglions of the rat has cholinergic receptors
[23,28], the signaling pathway between the paw and
vagal efferent nerves is to be elucidated.
Consistent with our previous findings [15], the present
results clearly shows that neither the anti-edematous
effect of AA nor the analgesic effect in mechanical
hyperalgesia was antagonized by naloxone. In contrast
to muscarinic receptors which play a significant role in
mediating both the anti-edematous and analgesic effects
of AA, opioid receptors have little role to play in the
current anti-inflammatory action of AA.
Our results show that AA attenuated edema and
inhibited mechanical hyperalgesia without affecting ther-
mal hyperalgesia. This is consistent with the results of a
previous study that electroacupuncture at body acu-
points attenuates mechanical hyperalgesia without
affecting thermal hyperalgesia in chronic pain due to
complete Freund’s adjuvant-induced inflammation [29].
The differential effect of AA on mechanical and thermal
hyperalgesia may be due to the fact that different recep-
tors and central circuits are responsible for different
types of hyperalgesia [30,31].
T h ep r e s e n ts t u d ya l s of o u n dt h a tt h et h e r m a lp a i n
threshold was significantly increased after AA and
administration of naloxone. This was unexpected
because neither AA nor naloxone alone altered the ther-
mal pain threshold in the CA-induced inflammation
model. While we do not have full explanation for such a
phenomenon, we suspect that it may have been caused
by a complex interaction between opioids, acetylcholine
and other neurochemicals released following AA [32,33].
It is worth noting that naloxone and naltrexone potenti-
ate the analgesic effect of electroacupuncture at body
acupoints as measured by tail-flick response to thermal
stimulation [34].
When we compared the results from the present study
with those from our previous body electroacupuncture
study [15], we found that the time course of the anti-
edematous effect of electroacupuncture was different. In
other words, in the same model of CA-induced inflam-
mation, body electroacupuncture was only effective
when given prior to induction of inflammation whereas
AA was effective when given either as pre-treatment or
post-treatment. CA-induced inflammation starts with a
nonphagocytic response occurring in the first 60 min-
utes after CA injection, followed by a phagocytic
response [27]. Our previous study indicates that body
electroacupuncture may be effective in inhibiting only
the nonphagocytic response, but not the phagocytic
response [15]. By contrast, AA may be effective in redu-
cing both nonphagocytic and phagocytic responses, sug-
gesting different mechanisms in body and auricular
electroacupuncture.
The stimulation parameters used in the present study
p r o v i d e sc l u e so ft h ef i b e rc l a s s e si n v o l v e d .I tw a s
reported that the mean threshold intensities of group II,
III and IV fibers in the saphenous nerve were 0.2, 0.5
and 3.0 mA respectively in response to electroacupunc-
t u r es t i m u l a t i o no fS T 3 6a t2 0H z ,0 . 5m sp u l s ed u r a -
tion [35,36]. As low frequency (4 Hz) and short pulse
duration (0.45 ms) was used in the present study, we
expect that few, if any, group IV or C fibers would be
excited at 0.7-1.0 mA. In human subjects we found that
0.7-1.0 mA auricular stimulation gave a strong but non-
painful stimulation [37]. Taken together, it would be
reasonable to assume that the 0.7-1.0 mA stimulation
used in our current experiments is a clinically relevant
intensity that stimulates mainly mylinated fibers. Further
studies are warranted to elucidate the exact neural path-
way between auricular afferents and muscarinic recep-
tors at the paw.
Taken together, the present data support the clinical
use of auricular acupuncture for pain conditions invol-
ving inflammation, and suggest that the therapeutic
properties of AA may be different from those of body
electroacupuncture.
Conclusion
T h i ss t u d yd i s c o v e r sar o l eo fp e r i p h e r a lm u s c a r i n i c
receptors in mediating the anti-inflammatory effects of
AA. The cholinergic muscarinic mechanism appears to
be more important than the opioid mechanism in the
anti-inflammatory action of AA.
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